Patient Blood Management

Why Participate?

  • Reduce patient harm: Reform transfusion practice

  • Learn how Western Australia is a world exemplar in PBM

  • Share strategies to meet #7 of the National Standards

  • Reclaim excess beddays

  • Reduce Blood product costs


Select Optional Activity R5 on your subscription agreement and return by email to


$A5,000 (plus GST) for first facility in your network $A4,000 for each additional facility.
Individual delegate venue fees are billed separately.

Improvement Group Name

Improving Patient Blood Management

26-27 June 2017 - Sydney
Meeting Code HRT1725

The Problem: International consensus:
10% of blood transfusions are appropriate
30% have uncertain benefits
60% inappropriate
Large variation in transfusion practice among Roundtable members.

The Opportunity: Patient Blood Management is an important safety and quality initiative with the potential to improve patient outcomes whilst also reducing hospital expenditure.

  • Red Blood Cell (RBC) transfusion is independently associated with increased morbidity, mortality, hospital and ICU length of stay, and increased cost.
  • On average, RBC transfused patients stay 2.5 days longer, with increased odds ratio of death of 1.7.
  • A recent West Australian study estimated the total hospital- associated cost of RBC transfusion across a five hospital health service to be $77 million per year.
  • Blood product costs will be devolved to public hospitals and incorporated into the ABF framework.
  • Existing wide variation: RBC transfusion rates vary from 8% to 93% in cardiac surgery, and 9-92% in orthopaedics. A large number of transfusions may be inappropriate and avoidable.
  • Australian NSQHS Standard 7 requires that hospitals have systems in place to ensure safe and appropriate prescribing and use of blood and blood products, and that they are consistent with national evidence-based guidelines.

The Solution: Can we afford NOT to do Patient Blood Management? Western Australia is a world exemplar in PBM, we can all implement workable solutions based on the WA strategies and experience.

The problem: Western Australia Metro Data on Transfusion and Cost Retrospective cohort study from a five hospital health service in Western Australia between (July 2011 - June 2012).

After adjusting for age, gender, admit type (emergency or elective), DRG and patient complexity (HRT complexity), compared with non-transfused:

  • Mean inpatient cost 1.83 Times higher in txed group.
  • Estimated total hospital associated cost of RBC transfusion AUD $77 million, representing 7.8% of total hospital expenditure on acute-care inpatients.
  • Significant dose-dependent association between the number of RBC units transfused and increased costs after adjusting for confounders.

Who should participate?
  • This Roundtable is intended to share "good practice" ideas and innovations for PBM programs.
  • Ideally, a cross- disciplinary team of those who are responsible for PBM.
  • You may bring up to five people per health service.
What does The Health Roundtable do?
  • Work with experts to identify key trends and innovations.
  • Survey participating health services for innovative practices.
  • Merge your pathology and Casemix data to benchmark blood utilisation.
  • Collate and analyse results.
  • Summarise the meeting and circulate all presentations.

Sydney Office

Suite 804
28 Foveaux Street
Surry Hills, NSW 2010

Call Us

In Australia: ‎+61 (02) 8041-1421‎

In New Zealand: +64 (09) 889 0332

© 1995-2017 The Health Roundtable   

Partners and Members